Hirschfield, G. M. Et Al. 2024. A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.. The New England journal of medicine , vol.390, no.9 , 783-794.

Hirschfield, G. M., Bowlus, C. L., Mayo, M. J., Kremer, A. E., Vierling, J. M., Kowdley, K. V., ... Levy, C.(2024). A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.. The New England journal of medicine , vol.390, no.9, 783-794.

Hirschfield, Gideon Et Al. "A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.," The New England journal of medicine , vol.390, no.9, 783-794, 2024

Hirschfield, Gideon M. Et Al. "A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.." The New England journal of medicine , vol.390, no.9, pp.783-794, 2024

Hirschfield, G. M. Et Al. (2024) . "A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.." The New England journal of medicine , vol.390, no.9, pp.783-794.

@article{article, author={Gideon M. Hirschfield Et Al. }, title={A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.}, journal={The New England journal of medicine}, year=2024, pages={783-794} }